Published in Blood Weekly, June 29th, 2006
"Neural stem cells have been documented in both the developing and the mature adult CNS of mammals. This cell population holds a considerable promise for therapeutic applications in a wide array of CNS diseases.
"Therefore, universally applicable strategies for the purification of this population to further its cell biological characterization are sought," investigators in Germany report.
According to A. von Holst and colleagues at Ruhr University Bochum, "Here, we report that the unique chondroitin sulfate epitope recognized by the monoclonal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-06-29)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.